New: NCI-funded clinical trial search
Mednet Logo

Does aspirin dose (81 mg vs 325 mg) matter for secondary stroke prevention?

Should some patients get 325 mg instead of 81mg at least for a certain amount of time, such as patients in the acute phase of ischemic stroke or patients with symptomatic intracranial atherosclerosis (SAMMPRIS trial)?
1 Answer
Mednet Member
Mednet MemberInvited Expert
Neurology · HCA Houston Healthcare
Answered on

This topic has been debated extensively. There are two camps in this debate:

  1. Aspirin with a dose of 81 mg is adequate for platelet inhibition in the general population.
  2. Aspirin with a dose of 325 mg may be needed for individuals who weigh more (>70 kg) to achieve appropriate platelet inhibition.

T...

Join for free or sign in to see the full answer